Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-28 @ 12:14 AM
Study NCT ID:
NCT05862194
Status:
COMPLETED
Last Update Posted:
2023-08-22
First Post:
2023-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC
Sponsor:
Yuhan Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-08
First Submit QC Date:
None
Study First Post Date:
2023-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-21
Last Update Post Date:
2023-08-22
Last Update Post Date Type:
ACTUAL